FDC Ltd

FDC Ltd | Sector: Pharmaceuticals | ISIN: INE258B01022

₹ 256.00 (2.28%) icon

29 Mar, 2023, 3:29:17 PM
Open
₹ 249.25
Prev. Close
₹ 250.30
Turnover(lac)
₹ 186.96
Day's High
₹ 258.50
Day's Low
₹ 249.25
52 Wk High
₹ 318.00
52 Wk Low
₹ 225.00
Book Value
₹ 127.31
Face Value
₹ 1.00
Mkt. Cap (Cr.)
₹ 4,247.30
P/E
23.85
EPS
10.74
Div. Yield
0.00

Stock View

info icon
Edit Image

STRONG BUY

Target | 16 Nov, 2022

350 (36.69%)

FDC Limited is an India-based company, which is principally engaged in the business of pharmaceuticals. The Company manufactures and distributes its range of generics, formulations and activ... Read More

KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 3/29/2023 3:29:17 PM

    ₹ 256 5.70 2.28
  • Open
  • ₹ 249.25
  • Prev. Close
  • ₹ 250.3
  • Turnover(Lac.)
  • ₹ 187
  • Day's High
  • ₹ 258.5
  • Day's Low
  • ₹ 249.25
  • 52 Week's High
  • ₹ 318
  • 52 Week's Low
  • ₹ 225
  • Book Value
  • ₹ 127.31
  • Face Value
  • ₹ 1
  • Mkt Cap (₹ Cr.)
  • 4,247.3
  • P/E
  • 23.85
  • EPS
  • 10.74
  • Divi. Yield
  • 0

Corporate Actions

31 Jan , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

31 Jan , 2023

12:00 AM

02 Nov , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

02 Nov , 2022

12:00 AM

30 Aug , 2022

12:00 AM

AGM

Announcement date: 30 Aug , 2022

View Details

21 Jul , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

21 Jul , 2022

12:00 AM

13 May , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

13 May , 2022

12:00 AM

29 Aug , 2022

12:00 AM

BookCloser

View Details

SHAREHOLDING SNAPSHOT
31 March , 2023 | 07:49 AM

PROMOTER - TOTAL69.50%

Indian: 69.50%

Foreign: 0%

NON-PROMOTER - TOTAL 30.50%

Institutions: 11.53%

Non-Institutions: 18.98%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

FDC Ltd News and Update

Article Image
  • 27 March, 2023 |
  • 4:08 PM

The valuation of the company was estimated to be up to $3 billion.

Image not found
  • IIFL News Service |
  • 24 March, 2023 |
  • 4:03 PM
Article Image
ad IconAd Image

FINANCIALS

PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT FDC Ltd

  • Mohan A Chandavarkar

  • Managing Director
  • Ashok A Chandavarkar

  • Director
  • Nandan M Chandavarkar

  • Joint Managing Director
  • Ameya A Chandavarkar

  • Executive Director & CEO
  • Ramdas A Chandavarkar

  • Chairman Emeritus
  • Varsharani Katre

  • Company Sec. & Compli. Officer
  • Nomita R Chandavarkar

  • Director
  • Swati S Mayekar

  • Independent Director
  • Uday Kumar Gurkar

  • Chairman & Independent Directo
  • MELARKODE GANESAN PARAMESWARAN

  • Independent Director
  • Usha Athreya Chandrasekhar

  • Independent Director
  • Mahesh Bijlani

  • Independent Director
  • Vijay Maniar

  • Addtnl Independent Director

Summary

FDC Limited is a fully integrated, research-oriented pharmaceutical company engaged in the manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs). FDCs formulation department designs and develops products for various global markets and the highly regulated markets of US and Europe. The company has built a visible presence in the Regulated and Emerging markets. Promoted as a partnership firm in 1936 by the late Anand Chandravarkar to import pharmaceutical dosage forms, specialised infant foods and surgical goods Fairdeal Corporation (P) Ltd, as the company was known, was converted into a private limited company in September 23rd, 1940. It set up a formulation unit at Jogeshwari, Bombay in 1949.FDC has 2 wholly owned subsidiaries namely FDC Inc., USA and FDC International Ltd, UK and 1 Joint Venture business, namely Fair Deal Corporation Pharmaceutical SA (Pty) Ltd. at South Africa as on 31 March 2019.FDC manufactures Electral, oral rehydration salt (ORS), being a leader in this segment. FDC manufactures bulk drugs, formulations and food products. The plant at Roha manufactures pharma dosage forms, food products and bulk drugs for the anti-rheumatic, anti-asthmatic, opthalmic and ENT segments. The company part financed its technical upgradation/modernisation/backward integration/expansion plans from the proceeds of its initial public issue in Jan.96. The company set up a modern manufacturing plant at Goa for manufacture... Read More


Reports by FDC Ltd


Reports by FDC Ltd